21:37 30/06/2016 BRIEF-Arena Pharmaceuticals to emphasize on its proprietary clinical stage ...
BRIEF-Arena Pharmaceuticals to emphasize on its proprietary clinical stage ...
Reuters - 9 hours ago
Arena Pharmaceuticals Inc says strategic shifting of priorities to emphasize its proprietary clinical stage pipeline. * Arena Pharmaceuticals Inc says implementation of additional cost reductions to streamline organization to support its development ...

21:15 30/06/2016 Arena Pharma to lay off 73% of workforce; shares halted
Arena Pharma to lay off 73% of workforce; shares halted
MarketWatch - 9 hours ago
Shares of Arena Pharmaceuticals Inc. ARNA, -2.29% were halted in the extended session Thursday after the biotech said it was reducing its workforce by 73% to focus on drugs in development.
Arena cuts 73% of workforce to trim operating costs - Seeking Alpha
Arena Pharmaceuticals Inc.: Arena Pharmaceuticals Announces Shift to Focus on ... - The Wall Street Transcript

16:22 29/06/2016 Arena Pharmaceuticals, Inc. Stock Momentum Hits Weakness
Arena Pharmaceuticals, Inc. Stock Momentum Hits Weakness
CML News - Jun 29, 2016
This is a momentum stock rating analysis for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) . The company has a two bull momentum rating which indicates some weakness.

13:00 24/06/2016 Two Biotechnology Names Are Hot: Sequenom Inc. (SQNM), Arena Pharmaceuticals ...
Two Biotechnology Names Are Hot: Sequenom Inc. (SQNM), Arena Pharmaceuticals ...
Zergwatch - Jun 24, 2016
Arena Pharmaceuticals, Inc. (ARNA) recently recorded 3.24 percent change and currently at $1.91 is 46.92 percent away from its 52-week low and down -62.7 percent versus its peak.

14:07 23/06/2016 Ariad Pharmaceuticals Inc. versus Arena Pharmaceuticals, Inc. Head to Head Compare
Ariad Pharmaceuticals Inc. versus Arena Pharmaceuticals, Inc. Head to Head Compare
CML News - Jun 23, 2016
Ariad Pharmaceuticals Inc. has a substantially higher fundamental rating then Arena Pharmaceuticals, Inc. which has an impact on the head-to-head comparison.

12:37 20/06/2016 Arena Pharmaceuticals, Inc. Stock Momentum at Critical Inflection Point
Arena Pharmaceuticals, Inc. Stock Momentum at Critical Inflection Point
CML News - Jun 20, 2016
This is a momentum stock rating analysis for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) . The company has a three bull momentum rating which indicates an inflection point.

12:22 15/06/2016 BRIEF-Arena Pharmaceuticals Inc announces appointment of Kevin Lind as CFO
BRIEF-Arena Pharmaceuticals Inc announces appointment of Kevin Lind as CFO
Reuters - Jun 15, 2016
June 15 Arena Pharmaceuticals Inc : * Arena Pharmaceuticals Inc says Kevin R. Lind will join its management team as executive vice president and chief financial officer, effective June 15 Source text for Eikon: Further company coverage: ...

13:45 09/06/2016 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Fundamental Star Rating Report
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Fundamental Star Rating Report
CML News - Jun 9, 2016
This is a fundamental star rating report for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) . The Capital Market Laboratories Star Rating is an objective, quantifiable measure of a company's operating and financial condition.

14:41 08/06/2016 What Wall Street is saying about Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
What Wall Street is saying about Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Zergwatch - Jun 8, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock is currently trading at about $1.96 and lots of rating firms seem to have a target price set on the stock.
Earnings Estimates Under Review: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - CWRU Observer
Revenue Estimates Spotlight: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - News Oracle

18:26 06/06/2016 ARENA PHARMACEUTICALS INC. (NASDAQ:ARNA) Financial Condition Compared to S&P 500
ARENA PHARMACEUTICALS INC. (NASDAQ:ARNA) Financial Condition Compared to S&P 500
CML News - Jun 6, 2016
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) has a Return on Assets of -20.02%. To compare, the S&P 500 oscillates between 1% and 4%.